Literature DB >> 20178534

Cytogenetic aberrations and the development of uterine leiomyomata.

Mohamed N El-Gharib1, Ezzat S Elsobky.   

Abstract

This study was conducted to define the cytogenetically critical regions of uterine leiomyomata, hoping to demonstrate the presence of possible genes involved in their evolution. It was carried out on 25 randomly selected uterine leiomyoma specimens obtained from 16 patients during hysterectomy or myomectomy operations. Successful tissue culture and karyotyping were performed in 19 specimens. There was no correlation between patient age, gravidity, or presenting symptom and the presence of chromosomal abnormality. A significant correlation was found between short culture turnaround time and the occurrence of chromosomal abnormality. Abnormal clonal karyotypes were present in 6 specimens, non-clonal abnormalities in 4 specimens and normal karyotypes were found in 9 specimens. Myomas with cross section >4 cm showed an increased incidence of abnormal karyotypes and a statistically significant higher incidence of clonal abnormalities. On the other hand, submucous myomas presented fewer clonal abnormalities than did intramural or subserosal myomas. Clonal chromosomal abnormalities involved 5 different chromosomes (2, 7, 8, 12, 22), which indicate genetic heterogeneity of such benign tumors and the need of molecular cytogenetic studies or molecular studies to characterize possible candidate genes at specific chromosomal breakpoints.

Entities:  

Mesh:

Year:  2010        PMID: 20178534     DOI: 10.1111/j.1447-0756.2009.01099.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  10 in total

1.  A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids.

Authors:  Pei-Chieng Cha; Atsushi Takahashi; Naoya Hosono; Siew-Kee Low; Naoyuki Kamatani; Michiaki Kubo; Yusuke Nakamura
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

2.  BET1L and TNRC6B associate with uterine fibroid risk among European Americans.

Authors:  Todd L Edwards; Kara A Michels; Katherine E Hartmann; Digna R Velez Edwards
Journal:  Hum Genet       Date:  2013-04-19       Impact factor: 4.132

3.  Variants in BET1L and TNRC6B associate with increasing fibroid volume and fibroid type among European Americans.

Authors:  Todd L Edwards; Katherine E Hartmann; Digna R Velez Edwards
Journal:  Hum Genet       Date:  2013-07-28       Impact factor: 4.132

Review 4.  Macrophages and Immune Responses in Uterine Fibroids.

Authors:  Alessandro Zannotti; Stefania Greco; Pamela Pellegrino; Federica Giantomassi; Giovanni Delli Carpini; Gaia Goteri; Andrea Ciavattini; Pasquapina Ciarmela
Journal:  Cells       Date:  2021-04-22       Impact factor: 6.600

Review 5.  Role of Transforming Growth Factor β in Uterine Fibroid Biology.

Authors:  Michał Ciebiera; Marta Włodarczyk; Małgorzata Wrzosek; Błażej Męczekalski; Grażyna Nowicka; Krzysztof Łukaszuk; Magdalena Ciebiera; Aneta Słabuszewska-Jóźwiak; Grzegorz Jakiel
Journal:  Int J Mol Sci       Date:  2017-11-17       Impact factor: 5.923

6.  A Trans-Ethnic Genome-Wide Association Study of Uterine Fibroids.

Authors:  Todd L Edwards; Ayush Giri; Jacklyn N Hellwege; Katherine E Hartmann; Elizabeth A Stewart; Janina M Jeff; Michael J Bray; Sarah A Pendergrass; Eric S Torstenson; Jacob M Keaton; Sarah H Jones; Radhika P Gogoi; Helena Kuivaniemi; Kathryn L Jackson; Abel N Kho; Iftikhar J Kullo; Catherine A McCarty; Hae Kyung Im; Jennifer A Pacheco; Jyotishman Pathak; Marc S Williams; Gerard Tromp; Eimear E Kenny; Peggy L Peissig; Joshua C Denny; Dan M Roden; Digna R Velez Edwards
Journal:  Front Genet       Date:  2019-06-12       Impact factor: 4.599

7.  An integrative genomic and transcriptomic analysis reveals potential targets associated with cell proliferation in uterine leiomyomas.

Authors:  Priscila Daniele Ramos Cirilo; Fábio Albuquerque Marchi; Mateus de Camargo Barros Filho; Rafael Malagoli Rocha; Maria Aparecida Custódio Domingues; Igor Jurisica; Anagloria Pontes; Silvia Regina Rogatto
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

8.  The genetic bases of uterine fibroids; a review.

Authors:  Veronica Medikare; Lakshmi Rao Kandukuri; Venkateshwari Ananthapur; Mamata Deenadayal; Pratibha Nallari
Journal:  J Reprod Infertil       Date:  2011-07

9.  Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis.

Authors:  Cuiling Qi; Yang Yang; Yongxia Yang; Jialin Li; Qin Zhou; Yinxin Wen; Cuiling Zeng; Lingyun Zheng; Qianqian Zhang; Jiangchao Li; Xiaodong He; Jia Zhou; Chunkui Shao; Lijing Wang
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379

Review 10.  Vitamins and Uterine Fibroids: Current Data on Pathophysiology and Possible Clinical Relevance.

Authors:  Michał Ciebiera; Mohamed Ali; Magdalena Zgliczyńska; Maciej Skrzypczak; Ayman Al-Hendy
Journal:  Int J Mol Sci       Date:  2020-08-01       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.